Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGENOMICS INCNEO · Entity 2096 | VP and Chief Culture Officer | December 30, 2021 | December 30, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGENOMICS INC
Report date December 30, 2021 · Filed December 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,615 |
Reported balance
After 2021-12-30 transaction · row 1
1 source rowRow 1 · 2021-12-30 · Grant · Acquired 21,400 · Balance 48,615 F1: On December 30, 2021, Ms. Balliet was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.52 · Expires 2022-04-28 | Direct | 7,000 |
Reported balance
Holding disclosure · report date 2021-12-30 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 7,000 F2: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.03 · Expires 2023-02-26 | Direct | 33,334 |
Reported balance
Holding disclosure · report date 2021-12-30 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 33,334 F3: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.60 · Expires 2024-03-01 | Direct | 17,496 |
Reported balance
Holding disclosure · report date 2021-12-30 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 17,496 F4: On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.33 · Expires 2027-03-02 | Direct | 15,006 |
Reported balance
Holding disclosure · report date 2021-12-30 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 15,006 F5: On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.17 · Expires 2028-03-02 | Direct | 10,551 |
Reported balance
Holding disclosure · report date 2021-12-30 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,551 F6: On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.95 · Expires 2028-07-05 | Direct | 4,050 |
Reported balance
Holding disclosure · report date 2021-12-30 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 4,050 F7: On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 30, 2021, Ms. Balliet was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
F2: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.
F3: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F4: On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F5: On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F6: On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F7: On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2021 Filed Dec 30, 2021 23:03 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000274 · wf-form4_164090540384967.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,615 F1 · kind: On December 30, 2021, Ms. Balliet was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:01 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 4,050 | $43.95 Strike: $43.95 | $177,997.50 |
DisclosureSEC source: 0001077183-21-000185 · wf-form4_162569887133383.xml · derivative · entry 7 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,050 Underlying: Common Stock · 4,050 shares Expires 2028-07-05 F6 · derivative.exercise_date: On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:01 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 758 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000185 · wf-form4_162569887133383.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,215 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 10,551 | $53.17 Strike: $53.17 | $560,996.67 |
DisclosureSEC source: 0001077183-21-000084 · wf-form4_161482068265167.xml · derivative · entry 8 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,551 Underlying: Common Stock · 10,551 shares Expires 2028-03-02 F7 · derivative.exercise_date: On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 1,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000084 · wf-form4_161482068265167.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,457 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 173 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000084 · wf-form4_161482068265167.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,595 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000084 · wf-form4_161482068265167.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,768 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock. Read SEC document |
| December 11, 2020 Filed Dec 11, 2020 22:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-20-000223 · wf-form4_160772744474977.xml · derivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 15,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 11, 2020 Filed Dec 11, 2020 22:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 15,000 | $49.99 | $749,850.00 |
DisclosureSEC source: 0001077183-20-000223 · wf-form4_160772744474977.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 Read SEC document |
| December 11, 2020 Filed Dec 11, 2020 22:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 15,000 | $8.03 | $120,450.00 |
DisclosureSEC source: 0001077183-20-000223 · wf-form4_160772744474977.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:01 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000175 · wf-form4_159657837366924.xml · derivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 13,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vest ratably over the first three anniversaries of the grant date. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:01 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 13,000 | $39.25 | $510,250.00 |
DisclosureSEC source: 0001077183-20-000175 · wf-form4_159657837366924.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:01 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 13,000 | $7.52 | $97,760.00 |
DisclosureSEC source: 0001077183-20-000175 · wf-form4_159657837366924.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 01:20 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock · Derivative | 15,006 | $28.33 Strike: $28.33 | $425,119.98 |
DisclosureSEC source: 0001077183-20-000041 · wf-form4_158328479579697.xml · derivative · entry 6 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,006 Underlying: Common Stock · 15,006 shares Expires 2027-03-02 F5 · derivative.exercise_date: On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 01:20 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 2,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000041 · wf-form4_158328479579697.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:20 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000041 · wf-form4_158328479579697.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,650 F1 · shares: Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 166 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-19-000212 · wf-form4_157409823242326.xml · derivative · entry 5 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,334 Underlying: Common Stock · 166 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,667 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000212 · wf-form4_157409823242326.xml · derivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 6,667 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Jennifer Balliet was granted 60,000 stock options which vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 6,833 | $23.45 | $160,233.85 |
DisclosureSEC source: 0001077183-19-000212 · wf-form4_157409823242326.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,862 Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 166 | $8.03 | $1,332.98 |
DisclosureSEC source: 0001077183-19-000212 · wf-form4_157409823242326.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 6,667 | $7.52 | $50,135.84 |
DisclosureSEC source: 0001077183-19-000212 · wf-form4_157409823242326.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed May 6, 2019 21:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 13,333 | $22.74 | $303,192.42 |
DisclosureSEC source: 0001077183-19-000059 · wf-form4_155717836502995.xml · nonDerivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,862 Read SEC document |
| May 03, 2019 Filed May 6, 2019 21:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 16,667 | $22.74 | $379,007.58 |
DisclosureSEC source: 0001077183-19-000059 · wf-form4_155717836502995.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,195 Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,333 | $7.52 Strike: $7.52 | $100,264.16 |
DisclosureSEC source: 0001077183-19-000059 · wf-form4_155717836502995.xml · derivative · entry 8 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,667 Underlying: Common Stock · 13,333 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date. Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,667 | $7.15 Strike: $7.15 | $119,169.05 |
DisclosureSEC source: 0001077183-19-000059 · wf-form4_155717836502995.xml · derivative · entry 5 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,667 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 13,333 | $7.52 | $100,264.16 |
DisclosureSEC source: 0001077183-19-000059 · wf-form4_155717836502995.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 16,667 | $7.15 | $119,169.05 |
DisclosureSEC source: 0001077183-19-000059 · wf-form4_155717836502995.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · derivative · entry 10 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,500 Underlying: Common Stock · 14,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 14,000 | $19.09 | $267,260.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 6 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,862 F1 · price: Average price of shares sold. Read SEC document |
| March 04, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 14,000 | $8.03 | $112,420.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 5 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 17,496 | $19.60 Strike: $19.60 | $342,921.60 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · derivative · entry 9 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,496 Underlying: Common Stock · 17,496 shares Expires 2024-03-01 F4 · derivative.exercise_date: On March 1, 2019, Ms. Balliet was granted 17,496 stock options which vested ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 2,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,862 Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · derivative · entry 8 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 20,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · derivative · entry 7 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 10,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Ms. Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 30,000 | $19.57 | $587,100.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: Average price of shares sold. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 10,000 | $8.03 | $80,300.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 20,000 | $7.52 | $150,400.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 01:40 UTC Amendment | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 6,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000113 · wf-form4a_154215960122504.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: This amended Form 4 reflects a correction to the amount of common stock holdings reported on the Form 4 filed on 5/31/2018. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 01:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 28,505 | $16.73 | $476,888.65 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 33,333 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · derivative · entry 6 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 33,333 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · derivative · entry 5 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 39,828 | $17.00 | $677,076.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,505 Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 35,000 | $4.78 | $167,300.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · derivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 65,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 35,000 | $11.70 | $409,500.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,322 F1 · price: Average price of shares sold Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 30,000 | $11.62 | $348,600.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,322 F1 · price: Average price of shares sold Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 65,000 | $4.78 | $310,700.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2018 Filed May 29, 2018 22:51 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionRestricted Stock · Derivative | 6,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000028 · wf-form4_152763425350108.xml · derivative · entry 5 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,334 Underlying: Common Stock · 6,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each share of restricted stock represents the contingent right to receive one share of common stock upon vesting. F5 · derivative.exercise_date: Restricted stock will vest as follows; 6,666 units vested on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020. F6 · derivative.expiration_date: These restricted stock will terminate upon the earliest of death, termination of employment or the last vesting date. Read SEC document |
| May 25, 2018 Filed May 29, 2018 22:51 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000028 · wf-form4_152763425350108.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.